Stein, Eytan M <br/><br/>
Molecular remission and response patterns in patients with mutant-  [electronic resource] 

 -  Blood  02 2019 
 - 676-687 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1528-0020 
<br/><br/><label>Standard No.: </label>10.1182/blood-2018-08-869008  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Aminopyridines--therapeutic use<br/>Biomarkers, Tumor<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Isocitrate Dehydrogenase--antagonists & inhibitors<br/>Leukemia, Myeloid, Acute--drug therapy<br/>Male<br/>Middle Aged<br/>Mutant Proteins--antagonists & inhibitors<br/>Mutation<br/>Neoplasm Recurrence, Local--drug therapy<br/>Prognosis<br/>Remission Induction<br/>Survival Rate<br/>Triazines--therapeutic use<br/>Young Adult